within Pharmacolibrary.Drugs.ATC.C;

model C09BX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.65,
    Cl             = 20 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Perindopril and bisoprolol is a fixed-dose combination medication used in the management of hypertension and other cardiovascular indications. Perindopril is an angiotensin-converting enzyme (ACE) inhibitor while bisoprolol is a selective beta-1 blocker. This combination is designed to provide synergistic blood pressure lowering effects and is approved for use today in many countries.</p><h4>Pharmacokinetics</h4><p>No population pharmacokinetic model published for the fixed-dose combination product C09BX02; below parameters are estimates based on known PK properties of individual components in healthy adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09BX02;
